Semaglutide injection (Wegovy) and liraglutide (Saxenda) are FDA-approved specifically for chronic weight management and can be used in post-bariatric patients
Team member, Inhaled Respiratory medicine Innovation and environmental Sustainability (IRIS) Group, Portugal Watch video Digital event video 10 October 2025, 10:00 - 11:30 CEST Mental health aspects of the impact of disaster and emergency situations More To mark World Mental Health Day, this event will address the profound impact disasters and emergency situations can have on mental health, affecting individuals and communities and leading to long-term complications
The gap between oral and injectable efficacy is closing as delivery technologies improve
This is a real phenomenon for a small subset of patients (approximately 5 to 8%) who are rapid metabolizers of tirzepatide
10, 2022 from Kim, H., Park, H., & Lee, S
A pill that requires fasting and precise timing creates a different behavioral burden than a once-weekly injection that some people set and forget